RBM20 and familial dilated cardiomyopathy: This finding is relevant to the mechanism(s) underlying the development of DCM in RBM20 mutation carriers as it indicates that RBM20 nucleocytoplasmic transport is the driving force only in patients harboring mutations in the NLS within the RS domain.